Nachrichten zu Bioalliance PharmaAct Nom. Cat-P
04.05.16
|
Onxeo S.A.: Publication of 2015 Reference Document (Businesswire)
|
|
02.05.16
|
||
28.04.16
|
||
18.04.16
|
||
06.04.16
|
||
04.04.16
|
||
25.03.16
|
Onxeo Announces Closing of DNA Therapeutics Acquisition (Businesswire)
|
|
21.03.16
|
Onxeo Announces Establishment of U.S. Subsidiary (Businesswire)
|
|
16.03.16
|
||
16.03.16
|
||
29.02.16
|
||
26.02.16
|
||
22.02.16
|
||
17.02.16
|
||
25.01.16
|
||
07.01.16
|
||
17.12.15
|
Onxeo S.A.: Publication of Shareholders Letter (Businesswire)
|
|
15.12.15
|
Onxeo announces its financial calendar for 2016 (Businesswire)
|
|
06.12.15
|
||
18.11.15
|
||
18.11.15
|
|
|
09.11.15
|
||
05.11.15
|
Onxeo Reports Third Quarter 2015 Business Update (Businesswire)
|
|
28.10.15
|
Onxeo to attend upcoming investor events (Businesswire)
|
|
22.10.15
|
||
19.10.15
|
||
06.10.15
|
Onxeo Announces Evolution in the Board of Directors (Businesswire)
|
|
05.10.15
|
||
30.09.15
|
Onxeo S.A.: Publication of a New Letter to Shareholders (Businesswire)
|
|
22.09.15
|
||
17.09.15
|
||
15.09.15
|
Onxeo Files Application for Key Livatag® Patent (Businesswire)
|
|
08.09.15
|
Onxeo to present at InvestorDagen 2015 (Businesswire)
|
|
03.09.15
|
Onxeo S.A.: Publication of a Shareholders Letter (Businesswire)
|
|
03.09.15
|
||
31.08.15
|
||
05.08.15
|
||
30.07.15
|
||
30.07.15
|
|
|
21.07.15
|
||
08.07.15
|
||
07.07.15
|
||
30.06.15
|
||
23.06.15
|
||
18.06.15
|
||
04.06.15
|
||
03.06.15
|
||
28.05.15
|
||
26.05.15
|
||
20.05.15
|